A drug for the treatment of obesity of central action. The mechanism of action is due to selective inhibition of serotonin and norepinephrine reuptake, to a lesser extent - dopamine. Accelerates the onset and prolongs the feeling of satiety, which leads to a decrease in food intake. Increases energy expenditure by stimulating thermogenesis through mediated activation of β3-adrenoreceptors. Acts on both sides of the energy balance and promotes weight loss.